Elevated IL‐17A and IL‐22 regulate expression of inducible CD38 and Zap‐70 in chronic lymphocytic leukemia
Background In this study, we investigated the role and expression of interleukin (IL)−17A and IL‐22 in chronic lymphocytic leukemia. Methods We evaluated the expression of markers above on CLL by ELISA, qRT‐PCR, flow cytometric analysis and nonparametric Kruskal–Wallis test. Results Quantitative RT‐...
Gespeichert in:
Veröffentlicht in: | Cytometry. Part B, Clinical cytometry Clinical cytometry, 2018-01, Vol.94 (1), p.143-147 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
In this study, we investigated the role and expression of interleukin (IL)−17A and IL‐22 in chronic lymphocytic leukemia.
Methods
We evaluated the expression of markers above on CLL by ELISA, qRT‐PCR, flow cytometric analysis and nonparametric Kruskal–Wallis test.
Results
Quantitative RT‐PCR revealed that the mRNA levels of IL‐17A and IL‐22 in PBMCs of CLL patients were upregulated compared with those from healthy subjects (mean ± SD: 1.96 ± 0.232 vs.0.72 ± 0.15, P |
---|---|
ISSN: | 1552-4949 1552-4957 |
DOI: | 10.1002/cyto.b.21487 |